Want to see TSE:VIBE full AI Analyst Report?

Vibe Bioscience Ltd (VIBE) Price & Analysis

9 Followers

VIBE Stock Chart & Stats

C$0.45

C$0.05(12.50%)

At close: Jun 26 4:00 PM EDT

C$0.45

C$0.05(12.50%)

Day’s Range― - ―

52-Week RangeC$0.30 - C$0.95

Previous CloseN/A

Volume500.00

Average Volume (3M)6.19K

Market Cap

C$485.87K

Enterprise ValueC$1.78M

Total Cash (Recent Filing)C$909.58K

Total Debt (Recent Filing)C$2.38M

Price to Earnings (P/E)―

Beta2.15

Next Earnings

Aug 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.51

Shares Outstanding1,079,699

10 Day Avg. Volume10,465

30 Day Avg. Volume6,194

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)>-0.01

Price to Sales (P/S)0.00224

P/FCF Ratio2.29

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong TTM Revenue Rebound And Improving Gross MarginA large TTM revenue rebound alongside a ~43% gross margin indicates improving product-market fit and healthier unit economics. Sustained top-line recovery with higher margins supports future operating leverage and long-term earnings scalability if the revenue trend continues.

Turnaround To Positive Operating And Free Cash FlowConsistent positive operating and free cash flow marks a structural improvement in cash generation, reducing immediate funding dependency. Even modest positive cash flow can fund near-term operations and reinvestment, improving financial flexibility over the next several quarters if sustained.

Modest And Declining Absolute Debt LevelLow and decreasing nominal debt reduces leverage risk and interest burden, enhancing durability of the operating turnaround. With improving EBIT/EBITDA, the company has more capacity to allocate cash to growth or deleveraging, which supports a steadier capital structure long term.

Bears Say

Negative Shareholders' Equity (capital Structure Risk)Negative equity is a persistent structural weakness that limits the company's ability to absorb future losses and restricts access to conventional financing. It raises solvency concerns and may force dilutive financing or restrictive covenants, constraining strategic options for months to come.

Still Net Loss-making On A TTM BasisDespite operational progress, a TTM net loss and negative net margin indicate profitability is not yet secured. Persistent net losses limit retained earnings rebuild, impede balance-sheet repair, and mean the company remains reliant on continued improvement or external capital to reach durable profitability.

Cash Flow Is Small Relative To Revenue And Historically InconsistentPositive cash flow today is encouraging but modest versus revenue and has lacked consistency historically. This limited cushion increases vulnerability to demand or working-capital shocks and restricts capacity to invest steadily, posing a meaningful risk to sustaining growth.

Vibe Bioscience Ltd News

Vibe Growth Director to Reduce Stake with Share Sale

Vibe Bioscience Ltd ( ($TSE:VIBE) ) has shared an update. Mark Waldron, a director at Vibe Growth Corporation,...

1y ago

Vibe Growth Plans Strategic Share Consolidation

Vibe Bioscience Ltd (TSE:VIBE) has released an update. Vibe Growth Corporation, a leading cannabis company, has announced a...

2y ago

VIBE

VIBE FAQ

What was Vibe Bioscience Ltd’s price range in the past 12 months?

Vibe Bioscience Ltd lowest stock price was C$0.30 and its highest was C$0.95 in the past 12 months.

What is Vibe Bioscience Ltd’s market cap?

Vibe Bioscience Ltd’s market cap is C$485.87K.

When is Vibe Bioscience Ltd’s upcoming earnings report date?

Vibe Bioscience Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 25 days.

How were Vibe Bioscience Ltd’s earnings last quarter?

Currently, no data Available

Is Vibe Bioscience Ltd overvalued?

According to Wall Street analysts Vibe Bioscience Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vibe Bioscience Ltd pay dividends?

Vibe Bioscience Ltd does not currently pay dividends.

What is Vibe Bioscience Ltd’s EPS estimate?

Vibe Bioscience Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vibe Bioscience Ltd have?

Vibe Bioscience Ltd has 1,079,699 shares outstanding.

What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Vibe Bioscience Ltd?

Currently, no hedge funds are holding shares in TSE:VIBE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vibe Bioscience Ltd

Vibe Growth Corp. is a vertically integrated cannabis company. The firm operates retail dispensaries, cannabis greenhouse and indoor cultivation, commercial distribution and transportation, e-commerce and home delivery, and manufacturing of marijuana products. It operates through the following segments: Dispensaries, Cultivation, Real Estate, and Canada. The company was founded on January 19, 2011 and is headquartered in Vancouver, Canada.